GEFT, or Rho guanine nucleotide exchange factor 25, activators belong to a distinct chemical class that plays a pivotal role in cellular signaling pathways. These activators exert their influence on the Rho family of small GTPases, specifically targeting the RhoA protein. Rho GTPases are critical molecular switches that regulate various cellular processes, including cytoskeletal dynamics, cell migration, and gene expression. GEFT activators are characterized by their ability to modulate the activity of RhoA by promoting the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the RhoA protein. This activation of RhoA, in turn, triggers downstream signaling cascades that impact cellular functions.
Structurally, GEFT activators often possess unique chemical motifs that facilitate their interaction with RhoA and promote nucleotide exchange. The activation of RhoA by GEFT activators contributes to the intricate regulation of cellular morphology and motility. These small molecules serve as molecular switches themselves, fine-tuning the balance between active and inactive states of RhoA. The intricate interplay between GEFT activators and the RhoA GTPase highlights the complexity of cellular signaling networks. Understanding the mechanisms by which these activators influence cellular processes at the molecular level provides valuable insights into the fundamental biology of cell regulation and opens avenues for further exploration of their physiological roles.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
GPCR agonist, may activate downstream signaling cascades, potentially activating Rho GTPases and GEFT. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits Src kinase, a potential upstream regulator of Rho GTPases, suggesting an indirect activation mechanism for GEFT. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibition of ROCK, a downstream effector of Rho GTPases, may indirectly activate Rho signaling pathways and potentially activate GEFT. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibition of protein tyrosine phosphatases (PTPs) by Sodium Orthovanadate may indirectly enhance Rho GTPase activity, suggesting a potential activation mechanism for GEFT. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, can modulate intracellular calcium levels, potentially activating Rho signaling pathways and indirectly activating GEFT. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
NAC, as an antioxidant, might activate Rho GTPases by modulating reactive oxygen species (ROS), potentially activating GEFT indirectly. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Disruption of lipid rafts by Methyl-β-Cyclodextrin could affect the localization and activity of Rho GTPases, potentially activating GEFT indirectly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, as an activator of PKC, may modulate Rho GTPase activity, suggesting an indirect activation mechanism for potential GEFT activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, potentially activating Rho GTPase signaling and suggesting an indirect activation mechanism for GEFT. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF, a protease inhibitor, may impact signaling cascades involving proteases, indirectly affecting Rho GTPases and potentially activating GEFT. | ||||||